뉴욕의 직장암 임상 시험
직장암 관련 연구 21개가 뉴욕 내 여러 지역에서 참여자를 모집하고 있습니다.
뉴욕의 도시
공식 연구 텍스트(영어)
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Memorial Sloan Kettering Cancer Center ( Site 0095), New York
- Ellis Hospital ( Site 0098), Schenectady
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT06997497Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Columbia University, New York
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06128551A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy
- Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- 외 1개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07227636A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- NYU Langone Health Perlmutter Cancer Center, New York
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT07629960Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
- Memorial Sloan Kettering Commack - Limited Protocol Activities, Commack
- Memorial Sloan Kettering Westchester - Limited Protocol Activities, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- 외 1개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT04165772Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- University of Rochester Medical Center, Rochester
피험자 모집 중2상
18세 ~ 100세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT07292298Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- James J Peters VA Medical Center, The Bronx
피험자 모집 중건강한 지원자 환영
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT07283939Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
피험자 모집 중
45세 ~ 70세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT05080673A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.
- Weill Cornell Medical College, New York
- Brooklyn Methodist Hospital - NewYork Presbyterian, New York
- New York Presbyterian Hospital - Queens, New York
피험자 모집 중2상
18세 ~ 90세 · 모든 성별 · 2026. 7. 29. 업데이트됨 · NCT05024097Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
- Roswell Park Cancer Institute, Buffalo
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- 외 4개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 7. 14. 업데이트됨 · NCT06205485Integrated Cancer Repository for Cancer Research
- C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
- Faxton St. Luke's Healthcare, Mohawk Valley, Utica
피험자 모집 중관찰 연구건강한 지원자 환영
19세 ~ 110세 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT02012699The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer
- New York Presbyterian Brooklyn Methodist Hospital, Brooklyn
- Weill Cornell Medical College, New York
- New York Presbyterian Hospital - Queens, New York
피험자 모집 중
18세 ~ 90세 · 모든 성별 · 2026. 6. 15. 업데이트됨 · NCT05943210A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- NYU Langone Medical Center, New York
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 6. 12. 업데이트됨 · NCT06051695A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- 외 1개
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 6. 2. 업데이트됨 · NCT06637462Brodalumab in the Treatment of Immune-Related Adverse Events
- Columbia University Irving Medical Center, New York
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 5. 13. 업데이트됨 · NCT06673329A Study of Tucatinib and Trastuzumab in People With Rectal Cancer
- Memorial Sloan Kettering Cancer Center at Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- 외 1개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 5. 12. 업데이트됨 · NCT05672524Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
- Memorial Sloan Kettering Cancer Center, New York
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 3. 12. 업데이트됨 · NCT04668872Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)
- Columbia University Irving Medical Center, New York
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 2. 25. 업데이트됨 · NCT07433673SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Buffalo
- Massive Bio SYNERGY-AI site, Hempstead
- Massive Bio SYNERGY-AI site, Manhasset
- 외 2개
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- NYU Langone Health, New York
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2025. 9. 9. 업데이트됨 · NCT06682793Feasibility of Non-Operative Management of Rectal Cancer in a Rural Population
- Bassett Healthcare Network, Cooperstown
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2023. 3. 7. 업데이트됨 · NCT04245683ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.